Drug Type Chemical drugs |
Synonyms Atracurium besilate, Atracurium besilate (INN), Atracurium besylate (USP) + [6] |
Target |
Mechanism CHRNA2 inhibitors(cholinergic receptor nicotinic alpha 2 subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (23 Nov 1983), |
Regulation- |
Molecular FormulaC59H77N2O15S |
InChIKeyGLLXELVDCIFBPA-UHFFFAOYSA-M |
CAS Registry64228-81-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00758 | Atracurium Besylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | CN | 01 Jan 1997 | |
Muscle Hypotonia | US | 23 Nov 1983 |
Not Applicable | 34 | (Bispectral Index) | fpftozpbay(kkzjdmuryy) = texcpanura bvbduagsdq (inutstqtja, gqhfizxqtg - mxamgskqls) View more | - | 13 Jul 2020 | ||
(Clinical Signs) | fpftozpbay(kkzjdmuryy) = dnuivjlbis bvbduagsdq (inutstqtja, wwkqavhopv - ewaqxdalns) View more | ||||||
Not Applicable | - | 23 | mfwbpbfmya(gixwomljwc) = hompayrfvq ccfquwywpr (fesdhtckts, 23.6 - 29.8) | - | 19 Mar 2020 | ||
Phase 2/3 | - | 173 | opvlhfjeyl(rypeeffiwt): adjusted RD = -6.4 (95% CI, -21.0 to 8.1) View more | - | 01 May 2018 | ||